ANAPROX DS Drug Patent Profile
✉ Email this page to a colleague
When do Anaprox Ds patents expire, and what generic alternatives are available?
Anaprox Ds is a drug marketed by Atnahs Pharma Us and is included in one NDA.
The generic ingredient in ANAPROX DS is naproxen sodium. There are forty-two drug master file entries for this compound. One hundred and thirty-five suppliers are listed for this compound. Additional details are available on the naproxen sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Anaprox Ds
A generic version of ANAPROX DS was approved as naproxen sodium by CONTRACT PHARMACAL on January 13th, 1997.
Summary for ANAPROX DS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 93 |
Clinical Trials: | 13 |
Patent Applications: | 6,228 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ANAPROX DS |
DailyMed Link: | ANAPROX DS at DailyMed |
Recent Clinical Trials for ANAPROX DS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Northwestern Medical Group | Phase 2 |
Shirley Ryan AbilityLab | Phase 2 |
Apkar Apkarian | Phase 4 |
Pharmacology for ANAPROX DS
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for ANAPROX DS
US Patents and Regulatory Information for ANAPROX DS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Atnahs Pharma Us | ANAPROX DS | naproxen sodium | TABLET;ORAL | 018164-003 | Sep 30, 1987 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ANAPROX DS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Atnahs Pharma Us | ANAPROX DS | naproxen sodium | TABLET;ORAL | 018164-003 | Sep 30, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Atnahs Pharma Us | ANAPROX DS | naproxen sodium | TABLET;ORAL | 018164-003 | Sep 30, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Atnahs Pharma Us | ANAPROX DS | naproxen sodium | TABLET;ORAL | 018164-003 | Sep 30, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ANAPROX DS
See the table below for patents covering ANAPROX DS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Switzerland | 556810 | VERFAHREN ZUR HERSTELLUNG DER D-2-(6-METHOXY-2-NAPHTHYL)-PROPIONSAEURE. (2-(6-Methoxy-2-naphthyl) propionic acid prepns. - anti-pyretics, analgesics, anti-inflammatory agents) | ⤷ Try a Trial |
Netherlands | 7512107 | ⤷ Try a Trial | |
South Africa | 6909034 | ⤷ Try a Trial | |
Switzerland | 547247 | VERFAHREN ZUR HERSTELLUNG VON 2-(6-METHOXY-2-NAPHTHYL)1-PROPANOL. | ⤷ Try a Trial |
Sweden | 385116 | FORFARANDE FOR FRAMSTELLNING AV TERAPEUTISKT VERKSAMMA NAFTYLALKANOLER | ⤷ Try a Trial |
Switzerland | 536805 | Verfahren zur Herstellung von in 6'-Stellung substituierten 2-(2'-Naphthyl)-essigsäureestern | ⤷ Try a Trial |
Japan | S4840726 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ANAPROX DS
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1411900 | SPC/GB11/015 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
1411900 | 2011/016 | Ireland | ⤷ Try a Trial | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE MODIFIED-RELEASE TABLETS; NAT REGISTRATION NO/DATE: PA0970/060/001 20101221; FIRST REGISTRATION NO/DATE: PL17901/0263-0001 20101105 |
1411900 | 122012000052 | Germany | ⤷ Try a Trial | PRODUCT NAME: NAPROXEN MIT ESOMEPRAZOL; NAT. REGISTRATION NO/DATE: 85145.00.00 20120202; FIRST REGISTRATION: GROSSBRITANNIEN PL 17901/0263 - 0001 20101105 |
0984957 | PA2011005,C0984957 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126 |
1411900 | 18/2011 | Austria | ⤷ Try a Trial | PRODUCT NAME: NAPROXEN UND ESOMEPRAZOL SOWIE DEREN PHARMAZEUTISCH ANNEHMBARE SALZE; NAT. REGISTRATION NO/DATE: 1-29937 20110105; FIRST REGISTRATION: GB PL 17901/0263-0001 20101105 |
0984957 | SPC/GB11/013 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
1411900 | C300481 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: NAPROXEN EN ESOMEPRAZOL; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17901/0263-001 20101105 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |